Perspective

Our Perspective

  • The Casualty Playbook: It’s in Your Hands

    By Libby Benet|December 25, 2013|English

    Casualty insurance carriers today are more concerned than ever to find ways to grow their business, review the make-up of their portfolios or simply manage transactions better. Fortunately Gen Re has tools available that can help carriers examine...

    Read More
  • Critical Illness Experience Studies

    By Steve Rowley|December 21, 2013|English

    Once an insurance product is developed and sold, the next challenge is maintaining profitability while remaining competitive and relevant to the needs of the market. As a comparative newcomer to the U.S. life insurance industry, Critical Illness products...

    Read More
  • Bringing Big Data Under Control

    By Sabine Fahrig|December 18, 2013|English

    Big Data promises to make a huge difference to insurance companies in the context of marketing, underwriting and claims management. Today, capturing, storing and harnessing huge volumes of personal data on clients has become a priority, especially for...

    Read More
  • Individual Critical Illness Application Development

    By Steve Rowley|November 04, 2013|English

    An application for insurance is one of the most critical risk management tools available to an insurer. In the case of Critical Illness insurance, it is sometimes the only tool available for risk selection and usually the only document incorporated...

    Read More
  • The 2013 U.S. Critical Illness Insurance Market Survey

    By Steve Rowley|October 17, 2013|English

    Gen Re has just released the results of the 2013 Critical Illness Market Survey. We have been conducting surveys of the U.S. Critical Illness Insurance (CII) market since 2000 and conducting them in conjunction with the National Association for Critical...

    Read More
  • An Early Diagnosis of Challenges Ahead for Critical Illness Insurers

    By Adele Groyer |October 02, 2013|English

    Initiatives to sequence 100,000 individual genomes in the UK and to develop a DNA study of one million Americans will create a vast genetic dataset. There is pressure to return incidental, but relevant, findings to participants. Despite this aim being...

    Read More